Pharma — Juli 2024
-
BioArctic's Partner Eisai Says Leqembi Approved In Hong Kong For Alzheimer's Disease Treatment https://proinvestor.com/investornyt/1183677/bioarctics-partner-eisai-says-leqembi-approved-in-hong-kong-for-alzheimers-disease-treatment
-
Video: I den anden af de tre specials har Per inviteret bestyrelsesformand i ALK-Abelló Anders Hedegaard i studiet. De taler blandt andet om forskellen på at sidde i bestyrelse i Tyskland i forhold til i Danmark, samt om danske bestyrelser er en old boys club. https://proinvestor.com/boards/121469
-
Storbank løfter kursmål for Lundbeck - ser kurspotentiale på 32 pct. https://proinvestor.com/investornyt/1191551/storbank-lofter-kursmal-for-lundbeck-ser-kurspotentiale-pa-32-pct
-
Biotech Stocks Facing FDA Decision In August 2024 https://proinvestor.com/investornyt/1191575/biotech-stocks-facing-fda-decision-in-august-2024
Hello! It looks like you're interested in this conversation, but you don't have an account yet.
Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.
With your input, this post could be even better 💗
Tilmeld Log ind